REBECCA CLONCH: Open Payments
NPI 1548945082 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,690 in 106 payments from 22 companies in 2025. Trend: 2023 $345 · 2024 $1,536 · 2025 $1,690
Food & beverage: $1,690
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $216 |
| AstraZeneca Pharmaceuticals LP | 12 | $201 |
| ABBVIE INC. | 15 | $198 |
| PFIZER INC. | 15 | $189 |
| Lilly USA, LLC | 8 | $129 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 5 | $85 |
| GlaxoSmithKline, LLC. | 4 | $62 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Daiichi Sankyo Inc. | 2 | $56 |
Products named: MOUNJARO, REXULTI, NURTEC ODT, BREZTRI, VRAYLAR, XIFAXAN, FARXIGA, Wegovy.
Industry payments across TN — which companies pay providers there.
